Navigation Links
First-of-its-Kind Study Released at the SGNA 36th Annual Conference Reveals Inconsistency in GI Endoscope Reprocessing
Date:5/18/2009

ST. LOUIS, May 18 /PRNewswire/ -- Preliminary results from the first-of-its-kind Clinical Evaluation and Assessment of Endoscope Reprocessing (CLEANR) study was released today at the Society of Gastroenterology Nurses and Associates, Inc. (SGNA) 36th Annual Conference in St. Louis, MO. The study indicated that while there are written endoscope reprocessing guidelines in place at the sites who participated in the study, significant variation in manual reprocessing takes place, leading to challenges with achieving consistent gastrointestinal (GI) endoscope reprocessing practices. The observational study was led by Cori L. Ofstead, MSPH, of Ofstead & Associates, Inc., a healthcare research firm, and sponsored by Advanced Sterilization Products (ASP). Other key employee-related findings included:

  • Majority of experienced workers "disliked" some of the manual reprocessing tasks;
  • 70 percent felt pressure to work quickly;
  • More than half experienced discomfort associated with reprocessing;
  • Employees indicated that using more automated systems provided increased consistency and better compliance-related documentation than manual processing.

According to Cori L. Ofstead, MSPH, lead researcher, "This study shows that institutions have adopted written GI endoscope reprocessing guidelines, yet there are clearly suboptimal practices and wide variations in adherence within and between institutions. Our findings indicate the majority of employees experience occupational health problems attributed to reprocessing, and many of them dislike tasks associated with manual cleaning. We found that automation improves consistency and employee satisfaction. In accordance with Centers for Disease Control (CDC) guidelines, every facility should reexamine its practices, and seek ways to improve occupational health and reduce infection risks for patients."

Background on Study and Additional Findings

The CLEANR Study was conducted from October 2008 through April 2009 at six U.S. sites (only five provided data in the required timeframe) including two gastroenterology centers, three multi-specialty hospitals, and one outpatient surgery center. Participating sites used a variety of reprocessing methodologies ranging from manual cleaning with brushes to automated channel irrigators and other automated systems including the ASP EVOTECH(TM) Endoscope Cleaner and Reprocessor. The EVOTECH(TM) System is the first commercially available system in the U.S. that both cleans and high-level disinfects endoscopes. It does not eliminate bedside precleaning in procedure room and no manual cleaning is required when selecting a cycle that has a wash stage.

Managers were interviewed and individuals tasked with the responsibility of cleaning endoscopes after a GI procedure were surveyed and their actions documented by an observer. Managers at every site stated that written reprocessing policies were in place. Study results indicated that GI endoscope reprocessing time varied by the individual, and its variability resulted in:

  • Majority of endoscopes using traditional reprocessing techniques were not reprocessed in accordance with existing reprocessing guidelines.
  • Inconsistency in brushing, detergent flush, rinsing, alcohol flushes and forced-air drying times:
    • Brush times ranged from 10 seconds to 2:30 minutes.
    • Detergent flush times ranged from 18 seconds to 2:45 minutes.
    • Sites with consistent flush times were using an automated channel irrigator.
    • Rinsing times ranged from 76 seconds to 3:20 minutes.
    • Alcohol flushes were only documented in 39.5 percent of instances.
    • Forced air was used in 81.5 percent of instances.

"ASP realizes that ensuring proper GI endoscope reprocessing is a complex and challenging task, and not all facilities have these issues," said Barbara Trattler, Director, Clinical Education at ASP. "ASP will continue to partner with our customers and industry to increase awareness of best practices in reprocessing. We are also dedicated to developing new technology solutions such as the EVOTECH(TM) Endoscope Cleaner and Reprocessor - the first commercially available system to eliminate the labor-intensive manual cleaning of endoscopes - to help improve compliance and increase employee satisfaction."

About Ofstead & Associates, Inc.

Ofstead & Associates is an independent research organization that gathers, analyzes, interprets, and summarizes evidence-based scientific and clinical information for clinicians and healthcare industry executives. Since 1996, Ofstead has focused exclusively on providing customized research services for clients in the medical field. Ofstead is committed to fostering excellence in healthcare by combining tailored research services and medical insights with practical approaches for developing high-quality output.

About ASP

Advanced Sterilization Products (ASP), division of Ethicon, Inc., a Johnson & Johnson company, has a long track record of designing and delivering innovative infection prevention solutions. Our pioneering technology, global distribution, and established leadership position enable us to simplify the process of buying and operating infection prevention products and services every day, for thousands of medical facilities around the world. This in turn enables our customers to focus on what they do best - preventing infection and saving lives. www.evotechecr.com


'/>"/>
SOURCE Advanced Sterilization Products
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. First-of-Its-Kind Program Aims to Reduce Primary Barrier to Breastfeeding for Hourly and Lower-Wage Working Mothers
2. AltaMed Opens First-of-its-Kind Health Care Center in the Nation
3. Ortho-McNeil initiates first-of-its-kind skin infection registry
4. Baker Energy and Huber Receive First-of-its-Kind Award from Wyoming Department of Environmental Quality
5. Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial
6. Coalition to Prevent Deep-Vein Thrombosis (DVT) Turns Awareness Into Action as it Declares First-Of-Its-Kind National DVT Screening Day
7. First-of-Its-Kind National Online Survey Uncovers Obstacles to Comprehensive Healthcare for People With Schizophrenia
8. First-of-Its-Kind National Survey Uncovers Obstacles to Comprehensive Healthcare for People With Schizophrenia
9. Benefitfocus(R) Unwraps First-of-Its-Kind Healthcare Media Studio
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Study sees transient heart dysfunction in some long-distance runners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... ... the perfect set of tools for video editors that want to create the illusion of ... CEO of Pixel Film Studios. , Video editors using ProDOF can add realistic depth ... focus from one area into the next. ProDOF comes with 0.5 second, 1.0 second, ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Redwood Family Dermatology has recently joined their multi-specialty medical group. The dermatology ... of cosmetic services. , “We’re excited to add this excellent dermatology practice to ...
(Date:1/20/2017)... ... ... New ADA Portable Motion Trek BP 300 Lift. Built for durability, this pool lift is ... be wheeled out of the way and stored when not in use. It is freestanding ... feedback from customers into specific enhancements and created a new product that is built directly ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... International ... of nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in ... bodybuilder and nutritional scientist who was determined to create a line of products that ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Conference Call and Webcast to Follow Vanda Pharmaceuticals Inc. ... results for the fourth quarter of 2016 on Wednesday, February 15, ... ... PM ET on Wednesday, February 15, 2017, during which management will ... other corporate activities. To participate in the conference call, please dial ...
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin ... global anti-obesity drugs market is expected to grow at ... period and CAGR of 38.7% in the second half of the ... of 32.8% from 2016 to 2027. The market is estimated at ... in 2027. ...
(Date:1/19/2017)... 19, 2017  Sensus Healthcare, Inc. (NASDAQ: ... in the treatment of non-melanoma skin cancers and ... radiation therapy, today announced that it will report ... results on Thursday, February 2, 2017 after the market ... conference call with the investment community on Thursday, February ...
Breaking Medicine Technology: